Literature DB >> 32917645

Inflammation Modulation by Vitamin D and Calcium in the Morphologically Normal Colorectal Mucosa of Patients with Colorectal Adenoma in a Clinical Trial.

David Corley Gibbs1, Veronika Fedirko1,2, John A Baron3, Elizabeth L Barry4, W Dana Flanders1, Marjorie L McCullough5, Rami Yacoub1, Tapasya Raavi1, Robin E Rutherford6, March E Seabrook7, Roberd M Bostick8,2.   

Abstract

Increased COX-2 and decreased 15-hydroxyprostaglandin dehydrogenase (15-HPGD) expression promote prostaglandin-mediated inflammation and colorectal carcinogenesis. Experimental studies suggest that vitamin D and calcium may inhibit these pathways, but their effects on colorectal tissue COX-2 and 15-HPGD expression in humans are unknown. We tested the effects of supplemental vitamin D (1,000 IU/day) and/or calcium (1,200 mg/day) on COX-2 and 15-HPGD expression in the morphologically normal rectal mucosa from 62 paients with colorectal adenoma in a placebo-controlled chemoprevention trial. We measured biomarker expression using automated IHC and quantitative image analysis at baseline and 1-year follow-up, and assessed treatment effects using mixed linear models. The primary outcome was the COX-2/15-HPGD expression ratio, because these enzymes function as physiologic antagonists. After 1 year of treatment, the mean COX-2/15-HPGD expression ratio in full-length crypts proportionately decreased 47% in the vitamin D group (P = 0.001), 46% in the calcium group (P = 0.002), and 34% in the calcium + vitamin D group (P = 0.03), relative to the placebo group. Among individuals with the functional vitamin D-binding protein isoform DBP2 (GC rs4588*A), the COX-2/15-HPDG ratio decreased 70% (P = 0.0006), 75% (P = 0.0002), and 60% (P = 0.006) in the vitamin D, calcium, and combined supplementation groups, respectively, relative to placebo. These results show that vitamin D and calcium favorably modulate the balance of expression of COX-2 and 15-HPGD-biomarkers of inflammation that are strongly linked to colorectal carcinogenesis-in the normal-appearing colorectal mucosa of patients with colorectal adenoma (perhaps especially those with the DBP2 isoform). PREVENTION RELEVANCE: Supplemental calcium and vitamin D reduce indicators of cancer-promoting inflammation in normal colorectal tissue in humans, thus furthering our understanding of how they may help prevent colorectal cancer. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32917645      PMCID: PMC7947029          DOI: 10.1158/1940-6207.CAPR-20-0140

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  51 in total

1.  Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.

Authors:  Liying Dai; D Shevy Perera; Denis W King; Bridget R Southwell; Elizabeth Burcher; Lu Liu
Journal:  J Pharmacol Exp Ther       Date:  2011-09-28       Impact factor: 4.030

2.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.

Authors:  Laufey Steingrimsdottir; Orvar Gunnarsson; Olafur S Indridason; Leifur Franzson; Gunnar Sigurdsson
Journal:  JAMA       Date:  2005-11-09       Impact factor: 56.272

3.  Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

Authors:  Jacqueline Moreno; Aruna V Krishnan; Srilatha Swami; Larisa Nonn; Donna M Peehl; David Feldman
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

4.  Associations of Circulating 25-Hydroxyvitamin D3 Concentrations With Incident, Sporadic Colorectal Adenoma Risk According to Common Vitamin D-Binding Protein Isoforms.

Authors:  David C Gibbs; Veronika Fedirko; Caroline Um; Myron D Gross; Bharat Thyagarajan; Roberd M Bostick
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

5.  The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes.

Authors:  Scott R Macfarlane; Callum M Sloss; Pamela Cameron; Toru Kanke; Roderick C McKenzie; Robin Plevin
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 6.  Calcium intake and adiposity.

Authors:  Shamik J Parikh; Jack A Yanovski
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

Review 7.  The role of vitamin D in reducing cancer risk and progression.

Authors:  David Feldman; Aruna V Krishnan; Srilatha Swami; Edward Giovannucci; Brian J Feldman
Journal:  Nat Rev Cancer       Date:  2014-04-04       Impact factor: 60.716

8.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

Authors:  I I Singer; D W Kawka; S Schloemann; T Tessner; T Riehl; W F Stenson
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

Review 9.  Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment.

Authors:  Tomohiro Aoki; Shuh Narumiya
Journal:  Inflamm Regen       Date:  2017-03-01

10.  The ω-3 polyunsaturated fatty acids prevented colitis-associated carcinogenesis through blocking dissociation of β-catenin complex, inhibiting COX-2 through repressing NF-κB, and inducing 15-prostaglandin dehydrogenase.

Authors:  Young-Min Han; Migyeung Jeong; Jong-Min Park; Mi-Young Kim; Eun-Jin Go; Ji Young Cha; Kyung Jo Kim; Ki Baik Hahm
Journal:  Oncotarget       Date:  2016-09-27
View more
  1 in total

Review 1.  Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms.

Authors:  Alberto Muñoz; William B Grant
Journal:  Nutrients       Date:  2022-03-30       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.